Iovance Biotherapeutics
Sasidhar Naidu is a highly experienced professional who has held key IT and analytics leadership roles at various pharmaceutical and healthcare companies. With a strong background in data management and analytics, Sasidhar has led teams in building and operationalizing data solutions to optimize business decision-making capabilities. Naidu has a Master's degree in Computer Science and Bachelor's degree in Computer Science.
Iovance Biotherapeutics
6 followers
Iovance Biotherapeutics (NASDAQ: IOVA) aims to improve patient care for people living with cancer. Iovance is investigating T cell-based therapies, known as tumor infiltrating lymphocytes (TIL), which use a patient’s own immune cells to attack cancer.